Himuka AM Pharma is Drug Discovery in Japan that focus on clinical remission business. Founded in 2017. They cover business area such as developer, bioactive peptide, mucosal healing, clinical remission, development, new drug seed, improved adrenomedullin, healthcare professional, unmet medical need.
2017
( 7 years old in 2024 )
Clinical Remission
-
25 Building 5th floor
2-5-36 Takachiho-dori
Miyazaki, 880-0812
Japan
Private
developerbioactive peptidemucosal healingclinical remissiondevelopmentnew drug seedimproved adrenomedullinhealthcare professionalunmet medical need
* We use standard office opening hours in near Himuka AM Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Himuka AM Pharma is Drug Discovery business from Japan that founded in 2017 (7 years old in 2024), Himuka AM Pharma business is focusing on Clinical Remission.
Himuka AM Pharma headquarter office and corporate office address is located in 25 Building 5th floor 2-5-36 Takachiho-dori Miyazaki, 880-0812 Japan.
Himuka AM Pharma was founded in Japan.
In 2024, Himuka AM Pharma is currently focus on clinical remission sector.
Above is snippet of Google Trends for "clinical remission" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Himuka AM Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
